Body size‐adjusted dose analysis of pirfenidone in patients with interstitial pneumonia

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1843|23|3|318-324

ISSN： 1323-7799

Source： RESPIROLOGY (ELECTRONIC), Vol.23, Iss.3, 2018-03, pp. : 318-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis‐associated interstitial lung disease

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 2, 2018-02 ,pp. : 477-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar

By  

Cardiology, Vol. 133, Iss. 2, 2016-0 ,pp. : 69-72

Karger

Access to resources Recommend Favorite

Efficacy of Combined Therapy with Cyclosporin and Low-Dose Prednisolone in Interstitial Pneumonia Associated with Connective Tissue Disease

By  

Respiration, Vol. 87, Iss. 6, 2014-02 ,pp. : 469-477

Karger

Access to resources Recommend Favorite

Increased Levels of Interleukin-18 in Bronchoalveolar Lavage Fluid of Patients with Idiopathic Nonspecific Interstitial Pneumonia

By  

Respiration, Vol. 72, Iss. 1, 2005-02 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

Serial Evaluation of High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis in Usual Interstitial Pneumonia

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 413-419

Karger

Access to resources Recommend Favorite